NAGESHWARA V. DASARI to Histone Deacetylase Inhibitors
This is a "connection" page, showing publications NAGESHWARA V. DASARI has written about Histone Deacetylase Inhibitors.
Connection Strength
0.074
-
A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer. Invest New Drugs. 2013 Feb; 31(1):115-25.
Score: 0.074